The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•16 April 2026•

1 min read

PacBio and Covaris Partner to Advance Cancer Tumor Sequencing with HiFi Technology

Key Facts

1PacBio and Covaris announced a joint workflow enabling HiFi long-read sequencing of FFPE tumor samples.

PacBio and Covaris have announced a joint workflow designed to enable HiFi long-read sequencing of Formalin-Fixed Paraffin-Embedded (FFPE) tumor samples. This collaboration aims to significantly improve genetic data extraction from archived clinical samples, which are critical for cancer research. By combining advanced extraction techniques with streamlined library preparation, the partnership addresses the technical challenges of sequencing degraded DNA. This integration is expected to expand PacBio's addressable market within the clinical oncology sector. The move highlights a strategic effort to enhance the utility of long-read sequencing in precision medicine. Analysts view this technical milestone as a positive development for PacBio's competitive positioning in the genomics industry.